Roivant Sciences Ltd. — Director's Dealing 2025

Apr 24, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Roivant Sciences Ltd. (ROIV)
CIK: 0001635088
Period of Report: 2025-04-21

Reporting Person: Pulik Richard (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-04-21	Common Shares	A	141464	—	Acquired	407352	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-04-21	Stock Option (Right to Buy)	$10.04	A	180413	Acquired	2035-04-20	Common Shares (180413)	Direct

Footnotes

F1: Reflects an award of restricted stock units with respect to Common Shares ("RSUs") with a vesting commencement date of April 20, 2025. These RSUs service-vest as follows: (i) 25% on the date thirteen (13) months from the vesting commencement date; and (ii) in twelve (12) successive equal quarterly installments thereafter, measured from the date thirteen (13) months from the vesting commencement date, subject to the reporting person's continuous service through the applicable vesting date.

F2: Reflects an award of stock options to purchase Common Shares with a vesting commencement date of April 20, 2025. These options vest and become exercisable as follows: (i) 25% on the first anniversary of the vesting commencement date; and (ii) in thirty-six (36) successive equal monthly installments thereafter, measured from the first anniversary of the vesting commencement date, subject to the reporting person's continuous service through the applicable vesting date.